SPRAVATO® (Esketamine) for Treatment-Resistant Depression
SPRAVATO® (Esketamine) is a medication for treatment of depression that is administered in our office under the supervision of one of our psychiatric nurse practitioners for treatment of depression. It is a great alternative treatment for depression in patients who have not had successful experiences with conventional antidepressant medication.
SPRAVATO® treatments are administered as an intranasal spray and are done in our office under the supervision of a psychiatric nurse practitioner.
At Linden Point Clinical Associates P.C., we have a treatment area specifically designed for SPRAVATO® treatments. Our treatment area offers a balance of safety and staff accessibility during your treatment while still maintaining privacy. You will relax in a recliner during your treatment and may rest, listen to music, or watch something on your device while having your treatment. Our goal is to allow you to feel relaxed and comfortable while having your treatment.
Why SPRAVATO®?
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).
It might be time to talk to your doctor about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.
Proven Effective for Treatment-Resistant Depression
- You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).
- In a short-term study, more patients using SPRAVATO® plus oral antidepressant demonstrated rapid and superior reduction in depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant.
- Most of the reduction in depressive symptoms was seen in as little as 24 hours.
- Between 24 hours and four weeks, both groups continued to improve; the difference in improvement between the groups remained but did not appear to increase through four weeks.
Tolerability
- SPRAVATO® plus oral antidepressant offers a similar safety profile to previous trials with a minimal risk for weight gain and sexual dysfunction compared to placebo plus oral antidepressant.
- Weight gain observed in patients using SPRAVATO® plus oral antidepressant was similar to patients taking a placebo plus oral antidepressant.
- Sexual dysfunction was not seen in more than 2% of patients in the SPRAVATO® clinical trials.
“I am in a better place than I have been — maybe ever. I think that’s an amazing gift.”
Grace K.; Colorado Springs, Colorado
Success Stories
FAQ
Will my insurance cover it?
Most commercial insurances cover SPRAVATO® treatment with a low out-of-pocket co-pay for the patient.
Is it safe?
SPRAVATO® is an FDA-approved treatment for treatment-resistant depression that is safe and effective when administered as prescribed under supervision.
How do I get started with treatment?
Call our office and let us know you are interested in starting SPRAVATO® treatment and we can get you scheduled with one of our psychiatric nurse practitioners for an evaluation to make sure you meet the criteria for treatment. We will then coordinate with your insurance and get you started as soon as possible to get you feeling better!
Can I continue with my current psychiatric medication provider?
Absolutely! We are happy to work with your current med provider to allow you to continue to see them while you undergo SPRAVATO® treatments.
